Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-89.63	45.89	-442.59
Graham Fair Price	156.35	1.89	0.74
PEG	-97.99	-0.02	0.99
Price/Book	-16.02	2.60	3.09
Price/Cash Flow	-57.66	37.97	89.68
Prices/Earnings	-87.30	15.08	-118.76
Price/Sales	-38.50	13.62	22.15
Price/FCF	-57.66	37.97	89.68
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	29.34	0.53	0.41
Operating Margin	143.61	0.25	-0.10
ROA	559.82	0.04	< 0.005
ROE	< 0.005	0.04	561.14
ROIC	< 0.005	0.04	389.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	1.80	-99.89
Dividends QOQ	-0.97	1.79	84.81
EBIT QOQ	-1.60	4.27	167.36
EPS QOQ	-1.20	7.62	533.47
FCF QOQ	-0.68	0.95	40.05
Revenue QOQ	-0.16	0.34	112.88
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	268.12	207.91	-22.46
Days Sales Outstanding (DSO)	76.88	66.85	-13.04
Inventory Turnover	0.34	0.43	28.96
Debt/Capitalization	0.02	0.02	1.74
Quick Ratio	4.89	5.18	6.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.93	1.92	-0.30
Cash	0.56	0.59	4.62
Capex	-0.04	< 0.005	85.12
Free Cash Flow	0.07	0.13	97.74
Revenue	0.27	0.37	36.13
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	7.90	7.58	-3.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	32.52	-5.10	-84.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating